Investigation of the simple and appropriate method to evaluate renal function in patients with cancer undergoing cisplatin-based chemotherapy

Investigation of the simple and appropriate method to evaluate renal function in patients with cancer undergoing cisplatin-based chemotherapy - Investigation of the simple and appropriate method to evaluate renal function in patients with cancer undergoing cisplatin-based chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047038

Enrollment

100

Registered

2022-02-28

Start date

2022-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

Measurement of cisplatin concentrations in blood and urine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with histologically diagnosed cancer who are planned to receive cisplatin

Exclusion criteria

Exclusion criteria: Patients undergoing hemodialysis or peritoneal dialysis

Design outcomes

Primary

Measure	Time frame
Investigation of the simple and appropriate method to evaluate renal function	—

Countries

Japan

Contacts

Public ContactAkinari Sekine

Toranomon Hospital Nephrology Center

akinari-s@toranomon.gr.jp03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026